European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism
Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
LUKAS, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Bone and cartilage markers laboratory
Bottani, M.; IRCCS Istituto Ortopedico Galeazzi, Laboratory of Experimental Biochemistry & Molecular Biology, Milan, Italy
Aarsand, A. K.; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway, Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway, Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy
Coşkun, A.; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Atasehir, Istanbul, Turkey
Díaz-Garzón, J.; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy, Quality Analytical Commission of Spanish Society of Laboratory Medicine (SEQC-ML), Hospital Universitario La Paz, Madrid, Spain
Fernàndez-Calle, P.; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy, Quality Analytical Commission of Spanish Society of Laboratory Medicine (SEQC-ML), Hospital Universitario La Paz, Madrid, Spain
Guerra, E.; Laboratory Medicine, Ospedale San Raffaele, Milan, Italy
Locatelli, M.; Laboratory Medicine, Ospedale San Raffaele, Milan, Italy
Sandberg, S.; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway, Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway, Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
Carobene, A.; Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy, Laboratory Medicine, Ospedale San Raffaele, Milan, Italy
Åkesson, K.
Bhattoa, H. P.
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cooper, C.
Eastell, R.
Garnero, P.
Heijboer, A.
Jorgensen, N. R.
Kanis, J.
Makris, K.
Ulmer, C. Z.
Vasikaran, S.
on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism
Fraser CG (2001) The nature of biological variation. In: Biol. Var. From Princ. to Pract. AACC Press, Washington, pp 1–27
Fraser CG, Petersen PH (1999) Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 45:321–323 DOI: 10.1093/clinchem/45.3.321
Fraser CG (2009) Reference change values: the way forward in monitoring. Ann Clin Biochem 46:264–265. 10.1258/acb.2009.009006 DOI: 10.1258/acb.2009.009006
Simundic A-M, Kackov S, Miler M et al (2015) Terms and symbols used in studies on biological variation: the need for harmonization. Clin Chem 61:436–438. 10.1373/clinchem.2014.232694 DOI: 10.1373/clinchem.2014.232694
Perich C, Minchinela J, Ricós C, Fernández-Calle P, Alvarez V, Doménech MV, Simón M, Biosca C, Boned B, García-Lario JV, Cava F, Fernández-Fernández P, Fraser CG (2015) Biological variation database: structure and criteria used for generation and update. Clin Chem Lab Med 53:299–305. 10.1515/cclm-2014-0739 DOI: 10.1515/cclm-2014-0739
Aarsand AK, Røraas T, Fernandez-Calle P et al (2018) The biological variation data critical appraisal checklist: a standard for evaluating studies on biological variation. Clin Chem 64:501–514. 10.1373/clinchem.2017.281808 DOI: 10.1373/clinchem.2017.281808
Carobene A (2015) Reliability of biological variation data available in an online database: need for improvement. Clin Chem Lab Med 53:871–877. 10.1515/cclm-2014-1133 DOI: 10.1515/cclm-2014-1133
Aarsand AK, Fernandez-Calle P, Webster C, et al. (2019) The EFLM biological variation database. In: https://biologicalvariation.eu
González-Lao E, Corte Z, Simón M et al (2019) Systematic review of the biological variation data for diabetes related analytes. Clin Chim Acta 488:61–67. 10.1016/j.cca.2018.10.031 DOI: 10.1016/j.cca.2018.10.031
Díaz-Garzón J, Fernández-Calle P, Minchinela J et al (2019) Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clin Chim Acta 495:467–475. 10.1016/j.cca.2019.05.013 DOI: 10.1016/j.cca.2019.05.013
Alvarez L, Ricos C, Peris P et al (2000) Components of biological variation of biochemical markers of bone turnover in Paget’s bone disease. Bone 26:571–576 DOI: 10.1016/S8756-3282(00)00279-9
Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R (2002) Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30:886–890. 10.1016/S8756-3282(02)00728-7 DOI: 10.1016/S8756-3282(02)00728-7
Bauer DC, Garnero P, Harrison SL et al (2009) Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res 24:2032–2038. 10.1359/JBMR.090526 DOI: 10.1359/JBMR.090526
Garnero P, Mulleman D, Munoz F et al (2003) Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. J Bone Miner Res 18:1789–1794 DOI: 10.1359/jbmr.2003.18.10.1789
Nguyen TV, Nelson AE, Howe CJ, Seibel MJ, Baxter RC, Handelsman DJ, Kazlauskas R, Ho KK (2008) Within-subject variability and analytic imprecision of insulin like growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem 54:1268–1276. 10.1373/clinchem.2008.105726 DOI: 10.1373/clinchem.2008.105726
Stevenson HP, Leslie H, Sheridan B (1997) Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations. Ann Clin Biochem 34:317–318. 10.1177/000456329703400316 DOI: 10.1177/000456329703400316
Jensen JEB, Sørensen HA, Kollerup G et al (1994) Biological variation of biochemical bone markers. Scand J Clin Lab Invest 54:36–39. 10.3109/00365519409088575 DOI: 10.3109/00365519409088575
Hannon R, Blumsohn A, Naylor KER (1998) Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 13:1124–1133 DOI: 10.1359/jbmr.1998.13.7.1124
Panteghini M, Pagani F (1995) Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 55:609–616. 10.3109/00365519509110260 DOI: 10.3109/00365519509110260
Jabor A, Kubíček Z, Komrsková J et al (2019) Biological variation of intact fibroblast growth factor 23 measured on a fully automated chemiluminescent platform. Ann Clin Biochem Int J Lab Med 0:000456321982616. 10.1177/0004563219826161 DOI: 10.1177/0004563219826161
Carobene A, Strollo M, Jonker N, Barla G, Bartlett WA, Sandberg S, Sylte MS, Røraas T, Sølvik UØ, Fernandez-Calle P, Díaz-Garzón J, Tosato F, Plebani M, Coşkun A, Serteser M, Unsal I, Ceriotti F, Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine (2016) Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the working group on biological variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 54:1599–1608. 10.1515/cclm-2016-0035 DOI: 10.1515/cclm-2016-0035
Carobene A (2017) The European Biological Variation Study (EuBIVAS): delivery of updated biological variation estimates, a project by the working group on biological variation in the European Federation of Clinical Chemistry and Laboratory Medicine. J Lab Precis Med 2:70–70. 10.21037/jlpm.2017.08.13 DOI: 10.21037/jlpm.2017.08.13
Carobene A, Røraas T, Sølvik UØ, Sylte MS, Sandberg S, Guerra E, Marino I, Jonker N, Barla G, Bartlett WA, Fernandez-Calle P, Díaz-Garzón J, Tosato F, Plebani M, Coşkun A, Serteser M, Unsal I, Ceriotti F, European Biological Variation Study of the EFLM Working Group on Biological Variation (2017) Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clin Chem 63:1141–1150. 10.1373/clinchem.2016.269811 DOI: 10.1373/clinchem.2016.269811
Aarsand AK, Diaz-Garzon J, Fernandez-Calle P et al (2018) The EuBIVAS: within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clin Chem 64:1380–1393. 10.1373/clinchem.2018.288415 DOI: 10.1373/clinchem.2018.288415
Carobene A, Guerra E, Locatelli M et al (2018) Providing correct estimates of biological variation’ not an easy task. The example of S100-protein and neuron-specific enolase. Clin Chem 64:1537–1539. 10.1373/clinchem.2018.292169 DOI: 10.1373/clinchem.2018.292169
Røraas T, Støve B, Petersen PH, Sandberg S (2016) Biological variation: the effect of different distributions on estimated within-person variation and reference change values. Clin Chem 62:725–736. 10.1373/clinchem.2015.252296 DOI: 10.1373/clinchem.2015.252296
Snedecor GW, Cochran WG (1989) Statistical methods, 8th edn. Iowa State University Press, Iowa City (IA)
Cochran WG (1941) The distribution of the largest of a set of estimated variances as a fraction of their total. Ann Hum Genet 11:47–52
Dixon WJ (1953) Processing data for outliers. Biometrics 9:74. 10.2307/3001634 DOI: 10.2307/3001634
Burdick RK, Borror CM, Montgomery DC (2005) Design and analysis of gauge R and R studies: making decisions with confidence intervals in random and mixed ANOVA models (ASA-SIAM series on statistics and applied probability)title. ASA-SIAM, Philadelphia DOI: 10.1137/1.9780898718379
Diez-Perez A, Naylor KE, Abrahamsen B, Agnusdei D, Brandi ML, Cooper C, Dennison E, Eriksen EF, Gold DT, Guañabens N, Hadji P, Hiligsmann M, Horne R, Josse R, Kanis JA, Obermayer-Pietsch B, Prieto-Alhambra D, Reginster JY, Rizzoli R, Silverman S, Zillikens MC, Eastell R, Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society (2017) International Osteoporosis Foundation and European calcified tissue society working group. Recommendations for the screening of adherence to oral bisphosphonates. Osteoporos Int 28:767–774. 10.1007/s00198-017-3906-6 DOI: 10.1007/s00198-017-3906-6
Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A, Herrmann M, Jorgensen NR, Kanis J, Kaufman JM, Laslop A, Locquet M, Matijevic R, McCloskey E, Minisola S, Pikner R, Reginster JY, Rizzoli R, Szulc P, Vlaskovska M, Cavalier E (2019) Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis. Adv Ther 36:2811–2824. 10.1007/s12325-019-01063-9 DOI: 10.1007/s12325-019-01063-9
Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, Kanis JA (2011) International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis. Clin Chem Lab Med 49:1271–1274. 10.1515/CCLM.2011.602 DOI: 10.1515/CCLM.2011.602
Singer FR, Eyre DR (2008) Using biochemical markers of bone turnover in clinical practice. Cleve Clin J Med 75:739–750. 10.3949/ccjm.75.10.739 DOI: 10.3949/ccjm.75.10.739
Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK (2004) Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361–18369. 10.1074/jbc.M314324200 DOI: 10.1074/jbc.M314324200
Cloos PAC, Christgau S (2004) Characterization of aged osteocalcin fragments derived from bone resorption. Clin Lab 50:585–598
Biver E, Chopin F, Coiffier G et al (2012) Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Jt Bone Spine 79:20–25. 10.1016/j.jbspin.2011.05.003 DOI: 10.1016/j.jbspin.2011.05.003
Lee AJ, Hodges S, Eastell R (2000) Measurement of osteocalcin. Ann Clin Biochem 37:432–446. 10.1258/0004563001899573 DOI: 10.1258/0004563001899573
Garnero P, Mulleman D, Munoz F, Sornay-Rendu E, Delmas PD (2003) Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. J Bone Miner Res 18:1789–1794. 10.1359/jbmr.2003.18.10.1789 DOI: 10.1359/jbmr.2003.18.10.1789
Cavalier E, Lukas P, Carlisi A et al (2013) Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters. Clin Chim Acta 425:117–118. 10.1016/j.cca.2013.07.016 DOI: 10.1016/j.cca.2013.07.016
Cavalier E, Eastell R, Jørgensen NR et al (2019) A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (P1NP): a report from the IFCC-IOF Joint Committee for Bone Metabolism. Clin Chem Lab Med
Vasikaran SD, Bhattoa HP, Eastell R, et al. (2020) Harmonization of commercial assays for PINP; the way forward. Osteoporos. Int.
Woitge HW, Friedmann B, Suttner S, Farahmand I, Müller M, Schmidt-Gayk H, Baertsch P, Ziegler R, Seibel MJ (1998) Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res 13:1797–1804. 10.1359/jbmr.1998.13.12.1797 DOI: 10.1359/jbmr.1998.13.12.1797
Maïmoun L, Manetta J, Couret I, Dupuy AM, Mariano-Goulart D, Micallef JP, Peruchon E, Rossi M (2006) The intensity level of physical exercise and the bone metabolism response. Int J Sports Med 27:105–111. 10.1055/s-2005-837621 DOI: 10.1055/s-2005-837621
Morovat A, Catchpole A, Meurisse A et al (2013) IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin Chem Lab Med 51:2009–2018. 10.1515/cclm-2012-0531 DOI: 10.1515/cclm-2012-0531
Christgau S, Bjarnason NH, Rigault M et al (1998) Intra-individual variation and response to anti-resorptive therapy assessed by bone resorption measurements with the serum CTx™ one step ELISA. Ligand Assay 3:200–205
Rogers A, Glover SJ, Eastell R (2009) A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 45:1044–1052. 10.1016/j.bone.2009.07.089 DOI: 10.1016/j.bone.2009.07.089
Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey E, Walsh JS, Eastell R (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27:21–31. 10.1007/s00198-015-3145-7 DOI: 10.1007/s00198-015-3145-7
Souberbielle J-C, Prié D, Piketty M-L, Rothenbuhler A, Delanaye P, Chanson P, Cavalier E (2017) Evaluation of a new fully automated assay for plasma intact FGF23. Calcif Tissue Int 101:510–518. 10.1007/s00223-017-0307-y DOI: 10.1007/s00223-017-0307-y
Smith ER, Cai MM, McMahon LP, Holt SG (2012) Biological variability of plasma intact and C-terminal FGF23 measurements. J Clin Endocrinol Metab 97:3357–3365. 10.1210/jc.2012-1811 DOI: 10.1210/jc.2012-1811
Dalmeijer GW, van der Schouw YT, Vermeer C et al (2013) Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem 24:624–628. 10.1016/j.jnutbio.2012.02.012 DOI: 10.1016/j.jnutbio.2012.02.012
Cranenburg ECM, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ (2008) The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 45:427–436. 10.1159/000124863 DOI: 10.1159/000124863
Evenepoel P, Claes K, Meijers B et al (2018) Poor vitamin K status is associated with low bone mineral density and increased fracture risk in end-stage renal disease. J Bone Miner Res. 10.1002/jbmr.3608
Krueger T, Schlieper G, Schurgers L et al (2014) Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant 29:1633–1638. 10.1093/ndt/gft459 DOI: 10.1093/ndt/gft459
van Ballegooijen A, Beulens J, Schurgers L et al (2019) Effect of 6-month vitamin D supplementation on plasma matrix Gla protein in older adults. Nutrients 11:231. 10.3390/nu11020231 DOI: 10.3390/nu11020231
